Edition:
United Kingdom

People: China Regenerative Medicine International Ltd (8158.HK)

8158.HK on Hong Kong Stock

0.22HKD
3:02am BST
Change (% chg)

HK$0.00 (+0.46%)
Prev Close
HK$0.22
Open
HK$0.23
Day's High
HK$0.23
Day's Low
HK$0.23
Volume
5,000
Avg. Vol
1,367,008
52-wk High
HK$3.60
52-wk Low
HK$0.18

Yip, Ray 

Dr. Ray Yip is Chairman of the Board, Compliance Officer, Chief Medicine Officer, Global Chief Strategy Officer, Chief Development Strategy Officer of the Company. Dr. He has been an executive Director of the Company since 8 September 2017. He is also an Authorised Representative, a Compliance Officer, the Chief Medicine Officer, the Global Chief Strategy Officer, a member of Strategy Committee and a member of the remuneration committee of the Company. Dr. Yip joined the Group in February 2017 as a nonexecutive Director. He had been re-designated as an executive Director in September 2017. He is an international public health leader who has made a significant contribution to global health in the areas of nutrition, maternal and child health, HIV/AIDS and tobacco control. Dr. Yip has been working on emergency response to war and famine, long term program and policy development effort in the PRC in recent years. Dr. Yip was the founding director of the Chinese office of U.S. Centers for Disease Control and Prevention (the “CDC”) in 2013, and the China program director of the Bill and Melinda Gates Foundation (the “Foundation”) in 2017. Dr. Yip is known as a specialist for health and medical issues in the PRC.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --